Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Bullboard Posts
Comment by HaulJockeyon Dec 10, 2017 6:15pm
83 Views
Post# 27127439

RE:RE:Product sales

RE:RE:Product sales
goldbug27 wrote: They currently sell products online through their subsidiary Vergence as well as consultation services. They are sole distributor for the patented Raybot extraction machines. They plan to focus on North America and Europe for selling and services these. See their website and investor presentation for more: https://abattis.com/index.php/investors/

ATT also has a distribution agreement with South Korea through GD Pharma. See news release here:  https://abattis.com/index.php/2017/10/03/abattis-signs-definitive-distribution-agreement-with-gd-pharma-to-sell-abattis-products-in-south-korea/




I'm calling BULLSh*T on this one.

Pointing you to where they want you to look and still no explanation for Experion, sale of over 50% of Northern Vine, CEO in a lawsuit right now etc. Notice there is always "a plan to" involved with these guys. The Korea deal is nothing more than a middleman saying he knows a guy who knows a guy. It's a consulting firm, period. EVERYONE IS BUYING AND SELLING HEMP OIL, it's nothing new. Korea, really? They couldn't find a buyer closer to home? Ah, closer to home would be too easy for investors to track.

The only connection to Emerald is through Northern Vine and Emerald owns over half of it. So why invest in ATT? Any deal made for extraction of oils and testing etc., will be through Northern Vine right? Emerald owns 53% of Northern Vine, so again, why ATT? They are not partners, they are co-owners. If Emerald wanted to partner up, they would have acquired ATT!!! All they wanted was the LICENCE that came with Northern Vine, not the baggage that comes with ATT.

This is a complete turd IMO.

Bullboard Posts